Search
Emergent BioSolutions Inc
EBSAdd to Watchlist
6.230USD
0.0000.00%
Close 10-23 16:00（ET）
319.41MMarket Cap
LossP/E TTM
After-hours 19:00 (ET)6.230USD-0.015-0.24%
After-hours 19:00 (ET)Emergent BioSolutions Inc (EBS) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Emergent BioSolutions Inc in the past month.
Hold
0 Strong Buy
2 Buy
0 Hold
1 Sell
0 Strong Sell
Target Price
11.000USD+72.41%
EBS Analyst Recommendation Trends
In the current month, EBS has received 2 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. EBS average Analyst price target in the last month is 11.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
3
3
2
2
2
2
2
2
EBS Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
9
17
11
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
AbbVie Inc
ABBV
8
19
6
0
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Regeneron Pharmaceuticals Inc
REGN
7
15
9
0
0
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Financial Forecasting
Based on analysts' estimates, EBS EPS is projected to reach -0.390 in FY2026Q3, following reported EPS of -3.492 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.11
-0.25
0.11
-0.39
-0.08
Actual
-1.04
0.13
-3.49
--
--
Surprise
-1049.07%
+152.41%
-3274.77%
--
--
FAQs
What is Emergent BioSolutions Inc's expected revenue for the next quarter?
Emergent BioSolutions Inc's expected revenue is 123.20M.
What is Emergent BioSolutions Inc's price target?
Analysts forecast that Emergent BioSolutions Inc's price target is USD 11.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 10.00.
How have Emergent BioSolutions IncEBS's recent earnings per share performed?
The market expectation was USD -3.49, while Emergent BioSolutions IncEBS's earnings per share (EPS) for the previous quarter was USD 0.13. EPS for the next quarter is expected at USD -0.39.
What is the analyst rating for Emergent BioSolutions Inc?
Based on the ratings of Emergent BioSolutions Inc's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.